Circadian clocks signal and adapt to an ever-changing world by juggling a panoply of transcriptional and post-translational modifications. In this issue of Molecular Cell, Gustafson et al. (2017) report an additional requirement for accurate timekeeping, a cis/trans conformational flicker in the transcriptional activation domain of the core clock protein BMAL1.
Circadian clocks throughout plant and animal kingdoms optimize internal physiology in a world with a 24 hr day. These internal clocks in turn respond to changes in our environment, adapting to variations in sunrise, food availability, and temperature, to name just a few. The molecular heart of circadian clocks is a transcriptional-translational negative feedback loop. In diverse species, the transcriptional activators CLOCK and BMAL1 heterodimerize via PAS domains to drive expression of their repressors, the Cryptochrome (CRY) and Period (PER) proteins (Dibner et al., 2010) . To achieve robust and entrainable circadian rhythms, the core clock proteins undergo diverse post-translational modifications (PTMs) including phosphorylation, ubiquitylation, acetylation, sumoylation, and O-GlcNAcylation. These PTMs control protein stability and function to determine clock speed and period length (Gallego and Virshup, 2007; Hirano et al., 2016) . In this issue of Molecular Cell, Gustafson et al. (2017) propose a new addition to the list of PTMs regulating clock speed. They report a conformational switch in the transactivation domain (TAD) of BMAL1, the cis-trans isomerization of an imide bond in a conserved penultimate proline residue that can modulate circadian rhythms.
The appreciation of specific PTMs controlling the clock began with the identification of a missense mutation in the serine/threonine kinase CK1ε (casein kinase 1 ε) in golden Syrian hamsters that caused a short circadian period (Lowrey et al., 2000) . We now appreciate a diversity of kinases, phosphatases, ubiquitin ligases, and deubiquitylases as well as other enzymes that modify PER and CRY proteins to regulate their stability and activity and hence control clock speed (Gallego and Virshup, 2007; Hirano et al., 2016) .
The protein stability and the transcriptional activity of CLOCK:BMAL1 is also regulated by PTMs. CLOCK and BMAL1 dimerize via PAS domains and recognize genomic E-box consensus sites via their bHLH domains (Gallego and Virshup, 2007; Hirano et al., 2016) . Their C-terminal regions recruit transcriptional co-activators (see Figure 1) . Specifically, the Transactivation Domain (TAD) of BMAL1 acts as a docking platform for positive and negative transcriptional co-regulators (Kiyohara et al., 2006) . Recently, the Partch and Liu labs reported that the TAD of BMAL1 acts as a functional switch, where CRY1 actively competes for binding with the transcriptional coactivator CBP/p300 to determine the transcriptional activity of CLOCK:BMAL1 ( Figure 1 ) and hence period length (Xu et al., 2015) . Further studying the role of the TAD, in this issue the Partch lab reports the occurrence of an intrinsic conformational TAD switch. Using NMR spectroscopy, they find that the extreme C terminus of the BMAL1 TAD domain adopts two conformational states, alternating between a cis and trans form due to isomerization of a Trp-Pro imide bond.
The cis/trans isomerization of a peptidyl-prolyl imide bond preceding a proline residue is intrinsically slow. Consistent with its biological relevance, however, the isomerization of the TAD can be markedly accelerated in vitro by peptidy-prolyl isomerases (PPIases) of the cyclophilin family. Prolyl cis/trans isomerization is implicated in the regulation of diverse molecular processes including protein folding, cell cycle progression, cell signaling, and gene expression (Hanes, 2015) . By applying NMR spectroscopy analysis, Gustafson et al. (2017) first observed the existence of two conformations in the last eight amino acids (named the ''switch peptide'') of the TAD region of BMAL1 based on chemical shifts. Further analysis confirmed that the peptide bond between W624 and P625 exists in two distinct conformations, the cis and trans forms (Figure 1) . Interestingly, this domain is highly conserved in species having vertebrate-like clock architecture, from humans to invertebrates. Moreover, this TAD switch was not observed when P625 or W624 mutated to Ala, resulting in trans-locked conformations. Similarly, integration of a bulky analog 5,5-dimethyl Proline (dmP) in place of P625 resulted in a cis-locked form (Figure 1 ), suggesting that both the Trp and Pro residues are key partners in the TAD conformational switch.
Studying the in vivo relevance of dynamic cis/trans conformational exchange is often challenging due to a paucity of robust detection tools and the diverse functions of the PPIs. Several lines of evidence here support the conclusion that a rapid switch in cis-trans isomerization is important for circadian timing in vivo. First, as noted, the authors demonstrate that multiple cyclophilin family members are capable of catalyzing the isomerization of the purified TAD. Second, they demonstrate that cyclosporin A (CSA), a broad-specificity cyclophilin inhibitor, lengthened circadian period in a dose-dependent manner. Third, they measured the period of translocked BMAL1 mutants stably expressed in Bmal1 À/À :Per2 Luc cells. Mutants that affect the TAD tail wiggle-P625A, W624A, and W624A/P625A-all showed circadian periods that were 1-3 hr shorter. Of course, amino acid changes and drugs can produce phenotypes for diverse reasons. Importantly, they find that CSA's effect on period length is markedly diminished in the cells with trans-locked BMAL1 mutants, suggesting that the effect of CSA on circadian rhythms is largely mediated through altered isomerization of the BMAL1 TAD. How changes in the structure of the TAD alter BMAL1 activity is not yet known. The authors found that the cis, trans, and P625A mutants all interact equally as well as wild-type TAD with purified binding domains of CRY1 and CBP proteins. Whether an effect on formation or stability of larger co-activator complexes is altered in the setting of full-length proteins, and in vivo, remains to be determined.
The data here support the conclusion that rapid flicker, or cis/trans isomerization of the BMAL1 TAD, is a key feature of the core circadian clock. Factors affecting the circadian clock, such as sleep/wake cycle, activity, and metabolism, could therefore alter the activity of various PPIs and impact on the rate of cis/trans isomerization. Additional questions are, of course, raised by this study. Is the flicker from cis to trans a constitutive event, or is it regulated? How do changes in TAD isomerization alter the circadian clock transcriptional machinery? Which cyclophilins regulate BMAL1 in vivo? Can the PPIs and hence the TAD switch be influenced by external stimuli, and if so, how? Does the assembly of co-repressors on the TAD alter the rate of the switch by preventing binding of the relevant PPI? CSA is a clinically used immunosuppressive drug-does CSA administration alter the circadian rhythms of patients via the TAD switch?
The ability to fine-tune circadian rhythms appears to be critical for success in evolution. The rapid cis-trans isomerization of the transcriptional activation domain of BMAL1 adds another tool to the array of control mechanisms keeping life running on schedule.
